Ocrelizumab
| CAS No. | 637334-45-3 | Cat. No. | BCP47449 |
| Name | Ocrelizumab | ||
| Synonyms | |||
| Formula | M. Wt | ||
| Description | Ocrelizumab is an intravenously administered, humanized anti-CD20 monoclonal antibody approved for the treatment of adults with relapsing forms of multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS). |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.